Exelixis
EXEL
#1792
Rank
A$17.08 B
Marketcap
A$63.47
Share price
3.61%
Change (1 day)
18.42%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: A$71.21 AUD on 2000-07-26

Lowest end of day price: A$1.87 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 0.16%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$346.99 0.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$39.36 2.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$555.66 4.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$69.15 0.72%๐Ÿ‡ซ๐Ÿ‡ท France
A$176.29 1.82%๐Ÿ‡บ๐Ÿ‡ธ USA
A$89.63 4.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$87.08 1.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$1.49 13.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.69 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA